View Item 

Show simple item record

Redefining the “crown”: Approaching chemotherapy-induced alopecia among Black patients with breast cancer
dc.contributor.authorPleasant, Versha A.
dc.contributor.authorPurkiss, Ava S.
dc.contributor.authorMerjaver, Sofia D.
dc.date.accessioned2023-06-01T20:48:09Z
dc.date.available2024-07-01 16:48:08en
dc.date.available2023-06-01T20:48:09Z
dc.date.issued2023-06-01
dc.identifier.citationPleasant, Versha A.; Purkiss, Ava S.; Merjaver, Sofia D. (2023). "Redefining the “crown”: Approaching chemotherapy-induced alopecia among Black patients with breast cancer." Cancer 129(11): 1629-1633.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/176817
dc.publisherOxford Academic
dc.publisherWiley Periodicals, Inc.
dc.subject.otherchemotherapy
dc.subject.otherrace
dc.subject.otherbreast neoplasm
dc.subject.otherbreast cancer
dc.subject.otheralopecia
dc.titleRedefining the “crown”: Approaching chemotherapy-induced alopecia among Black patients with breast cancer
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/176817/1/cncr34732.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/176817/2/cncr34732_am.pdf
dc.identifier.doi10.1002/cncr.34732
dc.identifier.sourceCancer
dc.identifier.citedreferenceCoils to Locks. Accessed June 1, 2022. https://coilstolocs.com/
dc.identifier.citedreferenceRossi A, Caro G, Fortuna MC, Pigliacelli F, D’Arino A, Carlesimo M. Prevention and treatment of chemotherapy-induced alopecia. Dermatol Pract Concept. 2020; 10: e2020074. doi: 10.5826/dpc.1003a74
dc.identifier.citedreferenceBreed WPM, van den Hurk CJG, Peerbooms M. Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations. Expert Rev Dermatol. 2011; 6 ( 1 ): 109 - 25. doi: 10.1586/edm.10.76
dc.identifier.citedreferenceMacduff C, Mackenzie T, Hutcheon A, Melville L, Archibald H. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. Eur J Cancer Care. 2003; 12 ( 2 ): 154 - 61. doi: 10.1046/j.1365-2354.2003.00382.x
dc.identifier.citedreferenceShin H, Jo SJ, Kim DH, Kwon O, Myung S-K. Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer. 2015; 136 ( 5 ): E442 - 54. doi: 10.1002/ijc.29115
dc.identifier.citedreferenceRugo HS, Klein P, Melin SA, et al. Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer. JAMA. 2017; 317 ( 6 ): 606 - 14. doi: 10.1001/jama.2016.21038
dc.identifier.citedreferenceNangia J, Wang T, Osborne C, et al. Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP Randomized Clinical Trial. JAMA. 2017; 317 ( 6 ): 596 - 605. doi: 10.1001/jama.2016.20939
dc.identifier.citedreferenceDilawari A, Gallagher C, Alintah P, et al. Does scalp cooling have the same efficacy in Black patients receiving chemotherapy for breast cancer? Oncology. 2021; 26 ( 4 ): 292–e548. doi: 10.1002/onco.13690
dc.identifier.citedreferenceJanssen FEM, Van Leeuwen GMJ, Van Steenhoven AA. Modelling of temperature and perfusion during scalp cooling. Phys Med Biol. 2005; 50 ( 17 ): 4065 - 73. doi: 10.1088/0031-9155/50/17/010
dc.identifier.citedreferenceKomen MMC, Smorenburg CH, van den Hurk CJG, Nortier JWR. Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncology. 2013; 18 ( 7 ): 885 - 91. doi: 10.1634/theoncologist.2012-0332
dc.identifier.citedreferenceAraoye EF, Stearns V, Aguh C. Considerations for the use of scalp cooling devices in Black patients. J Clin Oncol. 2020; 38 ( 30 ): 3575 - 6. doi: 10.1200/jco.20.02130
dc.identifier.citedreferenceShades of Melanin. Accessed June 1, 2022. https://shadesofmelaninhair.com/
dc.identifier.citedreferenceMolamodi K, Fajuyigbe D, Sewraj P, et al. Quantifying the impact of braiding and combing on the integrity of natural African hair. Int J Cosmet Sci. 2021; 43 ( 3 ): 321 - 31. doi: 10.1111/ics.12699
dc.identifier.citedreferenceHaskin A, Aguh C. All hairstyles are not created equal: what the dermatologist needs to know about Black hairstyling practices and the risk of traction alopecia (TA). J Am Acad Dermatol. 2016; 75 ( 3 ): 606 - 11. doi: 10.1016/j.jaad.2016.02.1162
dc.identifier.citedreferenceSishi VNB, Van Wyk JC, Khumalo NP. The pH of lye and no-lye hair relaxers, including those advertised for children, is at levels that are corrosive to the skin. S Afr Med J. 2019; 109 ( 12 ): 941 - 6. doi: 10.7196/samj.2019.v109i12.14010
dc.identifier.citedreferenceMayo TT, Callender VD. The art of prevention: it’s too tight-loosen up and let your hair down. Int J Womens Dermatol. 2021; 7 ( 2 ): 174 - 9. doi: 10.1016/j.ijwd.2021.01.019
dc.identifier.citedreferenceMuth CC. Chemotherapy and hair loss. JAMA. 2017; 317 ( 6 ): 656. doi: 10.1001/jama.2016.21266
dc.identifier.citedreferenceWilson TE, Fraser-White M, Feldman J, et al. Hair salon stylists as breast cancer prevention lay health advisors for African American and Afro-Caribbean women. J Health Care Poor Underserved. 2008; 19 ( 1 ): 216 - 26. doi: 10.1353/hpu.2008.0017
dc.identifier.citedreferenceLinnan LA, Ferguson YO. Beauty salons: a promising health promotion setting for reaching and promoting health among African American women. Health Educ Behav. 2007; 34 ( 3 ): 517 - 30. doi: 10.1177/1090198106295531
dc.identifier.citedreferenceResnicow K, Andrews AM, Beach DK, et al. Randomized trial using hair stylists as lay health advisors to increase donation in African Americans. Ethn Dis. 2010; 20: 276 - 81.
dc.identifier.citedreferencePalmer KNB, Rivers PS, Melton FL, et al. Health promotion interventions for African Americans delivered in U.S. barbershops and hair salons-a systematic review. BMC Publ Health. 2021; 21 ( 1 ): 1553. doi: 10.1186/s12889-021-11584-0
dc.identifier.citedreferenceSadler GR, Ko CM, Wu P, Alisangco J, Castañeda SF, Kelly C. A cluster randomized controlled trial to increase breast cancer screening among African American women: the Black cosmetologists promoting health program. J Natl Med Assoc. 2011; 103 ( 8 ): 735 - 45. doi: 10.1016/s0027-9684(15)30413-2
dc.identifier.citedreferencePalmer KNB, Okechukwu A, Mantina NM, et al. Hair stylists as lay health workers: perspectives of Black women on salon-based health promotion. Inquiry. 2022; 59: 469580221093183. doi: 10.1177/00469580221093183
dc.identifier.citedreferenceCraig ML. Ain’t I a beauty queen? Black women, beauty, and the politics of race. Oxford Academic; 2002.
dc.identifier.citedreferenceMobile Catastrophic Insurance Claims Company Sued by EEOC for Race Discrimination over Hair Policy. US Equal Employment Opportunity Commission; 2013. Accessed February 6, 2023. https://www.eeoc.gov/newsroom/mobile-catastrophic-insurance-claims-company-sued-eeoc-race-discrimination-over-hair
dc.identifier.citedreferenceStubbs R. A wrestler was forced to cut his dreadlocks before a match. His town is still looking for answers. The Washington Post; 2019. Accessed February 6, 2023. https://www.washingtonpost.com/sports/2019/04/17/wrestler-was-forced-cut-his-dreadlocks-before-match-his-town-is-still-looking-answers/
dc.identifier.citedreferenceAmerican Screening Sued by EEOC for Race Discrimination. US Equal Employment Opportunity Commission; 2021. Accessed February 6, 2023. https://www.eeoc.gov/newsroom/american-screening-sued-eeoc-race-discrimination.
dc.identifier.citedreferenceCox C. Texas teen banned by high school from attending graduation after refusing to cut dreadlocks. USA Today; 2020. Accessed February 6, 2023. https://www.usatoday.com/story/news/nation/2020/01/24/black-texas-teen-barred-high-school-after-graduation-not-cutting-dreadlocks/4562210002/
dc.identifier.citedreferenceLee MS, Nambudiri VE. The CROWN act and dermatology: taking a stand against race-based hair discrimination. J Am Acad Dermatol. 2021; 84 ( 4 ): 1181 - 1182. doi: 10.1016/j.jaad.2020.11.065
dc.identifier.citedreferenceVersluis A, van Alphen K, Dercksen W, de Haas H, Kaptein AA, van den Hurk C. Looking bad: female patients drawing their representation of chemotherapy-induced alopecia. J Health Psychol. 2022; 27 ( 13 ): 3013 - 3027. doi: 10.1177/13591053221075503
dc.identifier.citedreferenceLemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psycho Oncol. 2008; 17 ( 4 ): 317 - 28. doi: 10.1002/pon.1245
dc.identifier.citedreferenceBoland V, Brady A-M, Drury A. The physical, psychological and social experiences of alopecia among women receiving chemotherapy: an integrative literature review. Eur J Oncol Nurs. 2020; 49: 101840. doi: 10.1016/j.ejon.2020.101840
dc.identifier.citedreferenceMcGarvey EL, Baum LD, Pinkerton RC, Rogers LM. Psychological sequelae and alopecia among women with cancer. Cancer Pract. 2001; 9 ( 6 ): 283 - 9. doi: 10.1111/j.1523-5394.2001.96007.pp.x
dc.identifier.citedreferenceWilson KB. And it’ll come back real baby fine: Black women’s experiences with hair loss and regrowth after chemotherapy for breast cancer treatment. Qual Health Res. 2022; 32 ( 7 ): 1071 - 1085. doi: 10.1177/10497323221091929
dc.identifier.citedreferenceNewman LA, Kaljee LM. Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg. 2017; 152 ( 5 ): 485 - 93. doi: 10.1001/jamasurg.2017.0005
dc.identifier.citedreferenceHester RH, Hortobagyi GN, Lim B. Inflammatory breast cancer: early recognition and diagnosis is critical. Am J Obstet Gynecol. 2021; 225 ( 4 ): 392 - 6. doi: 10.1016/j.ajog.2021.04.217
dc.identifier.citedreferenceStringer-Reasor EM, Elkhanany A, Khoury K, Simon MA, Newman LA. Disparities in breast cancer associated with African American identity. Am Soc Clin Oncol Educ Book. 2021 ( 41 ): e29 - 46. doi: 10.1200/edbk_319929
dc.identifier.citedreferenceAbraham HG, Xia Y, Mukherjee B, Merajver SD. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database. Breast Cancer Res Treat. 2021; 185 ( 1 ): 229 - 38. doi: 10.1007/s10549-020-05938-2
dc.identifier.citedreferenceKillelea BK, Yang VQ, Wang S-Y, et al. Racial differences in the use and outcome of neoadjuvant chemotherapy for breast cancer: results from the National Cancer Data Base. J Clin Oncol. 2015; 33 ( 36 ): 4267 - 76. doi: 10.1200/jco.2015.63.7801
dc.identifier.citedreferencePastoriza JM, Karagiannis GS, Lin J, et al. Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer. Clin Exp Metastasis. 2018; 35 ( 7 ): 613 - 23. doi: 10.1007/s10585-018-9932-8
dc.identifier.citedreferenceHrin ML, McMichael AJ. Chemotherapy-induced alopecia in African American women: a literature review demonstrates a knowledge gap. J Am Acad Dermatol. 2022; 86 ( 6 ): 1434 - 5. doi: 10.1016/j.jaad.2021.06.858
dc.identifier.citedreferenceBrowall M, Gaston-Johansson F, Danielson E. Postmenopausal women with breast cancer: their experiences of the chemotherapy treatment period. Cancer Nurs. 2006; 29 ( 1 ): 34 - 42. doi: 10.1097/00002820-200601000-00006
dc.identifier.citedreferenceFreedman TG. Social and cultural dimensions of hair loss in women treated for breast cancer. Cancer Nurs. 1994; 17 ( 4 ): 334 - 41. doi: 10.1097/00002820-199408000-00006
dc.identifier.citedreferenceRossi A, Fortuna MC, Caro G, et al. Chemotherapy-induced alopecia management: clinical experience and practical advice. J Cosmet Dermatol. 2017; 16 ( 4 ): 537 - 41. doi: 10.1111/jocd.12308
dc.identifier.citedreferenceRubio-Gonzalez B, Juhász M, Fortman J, Mesinkovska NA. Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review. Int J Dermatol. 2018; 57 ( 12 ): 1417 - 24. doi: 10.1111/ijd.13906
dc.identifier.citedreferenceMassey CS. A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy. Eur J Oncol Nurs. 2004; 8 ( 2 ): 121 - 30. doi: 10.1016/j.ejon.2003.10.006
dc.identifier.citedreferenceThompson JM, Park MK, Qureshi AA, Cho E. Race and alopecia areata amongst US women. J Investig Dermatol Symp Proc. 2018; 19 ( 1 ): S47 - 50. doi: 10.1016/j.jisp.2017.10.007
dc.identifier.citedreferenceGathers RC, Lim HW. Central centrifugal cicatricial alopecia: past, present, and future. J Am Acad Dermatol. 2009; 60 ( 4 ): 660 - 8. doi: 10.1016/j.jaad.2008.09.066
dc.identifier.citedreferenceBillero V, Miteva M. Traction alopecia: the root of the problem. Clin Cosmet Investig Dermatol. 2018; 11: 149 - 59. doi: 10.2147/ccid.s137296
dc.identifier.citedreferenceMasidonski P, Mahon SM. Permanent alopecia in women being treated for breast cancer. Clin J Oncol Nurs. 2009; 13: 13 - 4.
dc.identifier.citedreferenceZhou T, Han S, Zhu Z, Hu Y, Xing W. Interventions for preventing chemotherapy-induced alopecia: a systematic review and network meta-analysis of randomized controlled trials. Cancer Nurs. 2021; 44: E567 - 77.
dc.identifier.citedreferenceSoref CM, Fahl WE. A new strategy to prevent chemotherapy and radiotherapy-induced alopecia using topically applied vasoconstrictor. Int J Cancer. 2015; 136 ( 1 ): 195 - 203. doi: 10.1002/ijc.28961
dc.identifier.citedreferenceDuvic M, Lemak NA, Valero V, et al. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol. 1996; 35 ( 1 ): 74 - 8. doi: 10.1016/s0190-9622(96)90500-9
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr34732.pdf
Size:
507.6KB
Format:
PDF
View/Open
Name:
cncr34732_am.pdf
Size:
600.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.